MicroRNA let-7c (MIRLET7C; let-7c), miR-99a and miR-125b as prognostic markers of luminal breast cancer BriefCommunication Pages: 1420 - 1420
Chromosome 11 open reading frame 30 (C11orf30), calpain small subunit 1 ( CAPNS1 ; CAPN4 ), signal transducer and activator of transcription 6 (STAT6) and ankyrin repeat domain 27 (ANKRD27) as diagnostic markers for eosinophilic esophagitis (EoE) BriefCommunication Pages: 1419 - 1419
Tumor-selective delivery of antisense oligomers (antimiRs) against oncogenic microRNAs BriefCommunication Pages: 1418 - 1418
RNAi against therapeutic targets with short interfering ribonucleic neutrals (siRNNs) BriefCommunication Pages: 1417 - 1417
Extending therapeutic protein half-lives via fusion to affibodies with pH-dependent binding to neonatal Fc receptor BriefCommunication Pages: 1416 - 1416
Nanomolar-scale, high throughput chemical synthesis of drug-like molecules BriefCommunication Pages: 1415 - 1415
Angiopoietin 2 (ANG2; ANGPT2); placental growth factor (PGF; PlGF); tissue inhibitor of metalloproteinases 3 (TIMP3) BriefCommunication Pages: 1408 - 1408
c-jun N-terminal kinase (JNK); MAP kinase 1 (MAPK1; ERK-2); MAPK3 (ERK-1) BriefCommunication Pages: 1407 - 1407
Globohexaosylceramide (globo-H); stage-specific embryonic antigen-3 (SSEA-3); SSEA-4 BriefCommunication Pages: 1403 - 1403
Epidermal growth factor receptor 1 (EGFR1; ErbB1; HER1); HER2 (EGFR2; ErbB2; neu); HER3 (EGFR3; ErbB3); VEGF BriefCommunication Pages: 1402 - 1402
Cyclin dependent kinase 7 (CDK7); v-myc myelocytomatosis viral related oncogene neuroblastoma derived (MYCN; NMYC) BriefCommunication Pages: 1401 - 1401
Estrogen receptor; LYN kinase (LYN); phosphoinositide 3-kinase (PI3K) BriefCommunication Pages: 1399 - 1399
Mutant NRL family CARD domain containing 4 ( NLRC4 ) as a marker of familial cold autoinflammatory syndrome (FCAS) BriefCommunication Pages: 1393 - 1393
Mouse multiple myeloma (MM) model with constitutive IL-6 signal transducer (IL-6ST; gp130; CD130) expression BriefCommunication Pages: 1392 - 1392
Rapid diagnostic system to detect low levels of bacteria in blood BriefCommunication Pages: 1391 - 1391
Inducible Tet repressor protein (TetR)-RNA interaction system for control of Plasmodium falciparum gene expression BriefCommunication Pages: 1390 - 1390
Chromatin immunoprecipitation with reference exogenous genome (ChIP-Rx) BriefCommunication Pages: 1389 - 1389
E3 ubiquitin ligase; SMAD specific E3 ubiquitin protein ligase 2 (SMURF2); NEDD4 family E3 ubiquitin-protein ligase (RSP5) BriefCommunication Pages: 1388 - 1388
Receptor-interacting serine-threonine kinase 1 (RIPK1; RIP1); cyclophilin A (CYPA; PPIA) BriefCommunication Pages: 1387 - 1387
Glioma-associated oncogene homolog 1 zinc finger protein (GLI1) BriefCommunication Pages: 1386 - 1386
Transient receptor potential vanilloid 4 (TRPV4; VRL2); transforming growth factor β1 (TGFB1) BriefCommunication Pages: 1385 - 1385
Phosphoglycerate kinase 1 (PGK1); heat shock protein 90 (Hsp90) BriefCommunication Pages: 1383 - 1383
Piezo-type mechanosensitive ion channel component 1 (PIEZO1); PIEZO2 BriefCommunication Pages: 1382 - 1382
N-terminal acetyltransferase complex ARD1 subunit homolog A (NAA10; ARD1A; ARD1); runt-related transcription factor 2 (RUNX2) BriefCommunication Pages: 1381 - 1381
IL-18; IL-22; toll-like receptor 5 (TLR5); NRL family CARD domain containing 4 (NLRC4) BriefCommunication Pages: 1379 - 1379
BRAF; checkpoint kinase 1 (Chk1; CHEK1); Chk2 (CHEK2); ataxia telangiectasia mutated (ATM); VEGF BriefCommunication Pages: 1373 - 1373
AXL receptor tyrosine kinase (AXL; UFO); discoidin domain receptor tyrosine kinase 2 (DDR2); c-Met proto-oncogene (MET; HGFR); insulin-like growth factor-1 receptor (IGF1R; CD221) BriefCommunication Pages: 1372 - 1372
Nicotinamide adenine dinucleotide (NAD+); unconventional prefoldin RPB5 interactor (URI1; URI) BriefCommunication Pages: 1371 - 1371
